HilleVax Reports Positive Immunogenicity Results For Phase 2b Trial For HIL-214

RTTNews | 946 days ago
HilleVax Reports Positive Immunogenicity Results For Phase 2b Trial For HIL-214

(RTTNews) - Biopharmaceutical company HilleVax, Inc. (HLVX) reported Monday positive results from a prespecified immunogenicity analysis of the 203 subjects enrolled in the run-in cohort of NEST-IN1 (Norovirus Efficacy and Safety Trial for INfants), the company's ongoing Phase 2b trial for HIL-214, its investigational virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe norovirus-related acute gastroenteritis (AGE) in infants.

These results follow the previously announced positive recommendation from an independent safety data monitoring committee based on this same cohort.

NEST-IN1 is a Phase 2b, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy, safety, and immunogenicity of HIL-214 in infants of approximately 5 months of age at time of initial vaccination at sites in the United States and Latin America.

The study is planned to enroll 3,000 subjects who will be randomized 1:1 to receive a two-dose regimen of either HIL-214 or placebo.

The company said the full NEST-IN1 topline safety and efficacy data remains on-track for the second half of 2023.

For More Such Health News, visit rttnews.com

read more
Renewed Selling Pressure Likely For Japan Shares

Renewed Selling Pressure Likely For Japan Shares

The Japanese stock market bounced higher again on Tuesday, one day after ending the two-day winning streak in which it had added just 50 points or 0.2 percent. The Nikkei 225 now sits just beneath the 39,690-point plateau although it's likely to head south again on Wednesday.
RTTNews | 3 minutes ago
KOSPI May Run Out Of Steam On Wednesday

KOSPI May Run Out Of Steam On Wednesday

The South Korea stock market has finished higher in back-to-back sessions, collecting more than 60 points or 1.9 percent along the way. The KOSPI now sits just beneath the 3,115-point plateau although investors may lock in gains on Wednesday.
RTTNews | 18 minutes ago
New Zealand Interest Rate Decision Due On Wednesday

New Zealand Interest Rate Decision Due On Wednesday

The Reserve Bank of New Zealand will wrap up its monetary policy meeting on Wednesday and then announce its decision on interest rates, highlighting a busy day for Asia-Pacific economic activity. The RBNZ is expected to hold its Official Cash Rate steady at 3.25 percent.
RTTNews | 1h 18min ago
U.S. Dollar Higher As Trump Delays Tariff Deadline

U.S. Dollar Higher As Trump Delays Tariff Deadline

The U.S. dollar climbed against its major counterparts in the New York session on Tuesday, as President Donald Trump announced a delay in implementation of tariffs to August 1.
RTTNews | 1h 58min ago
Swiss Market Settles Marginally Up

Swiss Market Settles Marginally Up

Despite spending much of the day's trading session in negative territory, the Switzerland market closed marginally higher on Tuesday thanks to some brisk buying in the final minutes.
RTTNews | 4h 19min ago
European Markets Close On Positive Note

European Markets Close On Positive Note

European markets closed on a positive note on Tuesday, as investors shrugged off concerns about tariffs and picked up stocks, amid hopes major European countries will strike trade deals with the U.S. before the newly announced August 1 deadline.
RTTNews | 4h 41min ago